Parkwood LLC Atea Pharmaceuticals, Inc. Transaction History

Parkwood LLC

  • $1.42 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$5.5 - $9.19 $395,626 - $661,055
-71,932 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$7.67 - $44.59 $551,718 - $3.21 Million
71,932 New
71,932 $643,000
Q2 2021

Aug 13, 2021
SELL
$19.22 - $59.08 $160,314 - $492,786
-8,341 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$41.42 - $88.44 $345,484 - $737,678
8,341 New
8,341 $515,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $275M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Parkwood LLC Portfolio

Follow Parkwood LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email